Bronwen Bastone - 01 Mar 2024 Form 4 Insider Report for Enfusion, Inc.

Role
Chief People Officer
Signature
/s/ Matthew Campobasso, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
01 Mar 2024
Net transactions value
+$28,637
Form type
4
Filing time
05 Mar 2024, 20:20:58 UTC
Previous filing
10 Jan 2024
Next filing
22 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENFN Class A Common Stock Award $0 +104,603 +68% $0.000000 258,449 01 Mar 2024 Direct F1
transaction ENFN Class A Common Stock Award $45,162 +5,209 +2% $8.67 263,658 01 Mar 2024 Direct F2
transaction ENFN Class A Common Stock Tax liability $16,525 -1,906 -0.72% $8.67 261,752 01 Mar 2024 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units ("RSUs") awarded pursuant to the Enfusion, Inc. 2021 Stock Option and Incentive Plan (the "Plan"). The RSUs will vest in full as follows: 8,651, 8,651, 78,651 and 8,650 on each of March 1, 2025, 2026, 2027 and 2028.
F2 Consists of fully vested shares issued under the Plan (the "Vested Shares").
F3 Consists of shares withheld to satisfy tax withholding obligations resulting from delivery of the Vested Shares to the reporting person; not an open market transaction.